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1110Objectives:Acceptable coaptation cannot always be obtained using standard repair techniques. We assessed the
safety and mid-term results using a novel technique to address leaflet retraction or tethering in children with type
III mitral or tricuspid regurgitation as an addition to standard valve repair techniques.
Methods: Forty children were included, 36 for the mitral valve and 4 for the tricuspid valve, with a mean age of
11.3 3.9 years. A polypropylene suture was placed on the free edge of the retracted or tethered leaflet segment
and anchored to the atrial side of the opposite annulus. This avoided valve replacement in all patients. An ad-
ditional 40 children were matched for age, etiology, leaflet retraction or tethering, and surgery in which the sus-
pension stitch was not used and constituted the control group.
Results: The mean aortic crossclamp and cardiopulmonary bypass time was 36 9 and 57 9 minutes, respec-
tively. No early or late deaths occurred. At discharge, no patient had more than mild regurgitation with a gradient
of 4.4  2.4 mm Hg in the mitral position and 2  1.75 mm Hg in the tricuspid position. The results were not
significantly different than those of the control group. During a follow-up of 37.7  18.4 months, 3 patients re-
quired reoperation for mitral valve replacement in the suspension stitch group and 2 within the control group. At
echocardiography of the remaining patients, the repair remained stable, with no suspension suture breakage.
Conclusions: This suspension technique improved coaptation and resulted in avoidance or delay of valve re-
placement in patients with type III regurgitation, with an acceptable transvalvular gradient in most patients
that did not significantly increase with growth. (J Thorac Cardiovasc Surg 2010;140:1110-6)Video clip is available online.
Mitral and tricuspid valve repair, if technically feasible, re-
mains the procedure of choice for most etiologies of mitral
and tricuspid regurgitation. However, when the leaflets are
retracted or tethered as in type III regurgitation, acceptable
coaptation cannot always be obtained using standard repair
techniques, as described by Carpentier,1 such as ring annu-
loplasty, leaflet shaving, resection of the retracted second-
ary or primary chordae tendineae, and pericardial patch
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The Journal of Thoracic and Cardiovascular Surbeen proposed to specifically address retraction or tether-
ing, such as papillary muscle relocation,2-4 edge-to-edge
(Alfieri) repair,5 and ventricular remodeling.6,7
We have previously reported our initial experience with
suspension of the retracted posterior leaflet free edge to
the ipsilateral annuloplasty ring in 10 rheumatic patients.8
This suspension stitch was conceived by one of us (A.K.)
and refined by suspending the leaflet free edge to the contra-
lateral annulus, to allow for better coaptation. The aim of
the present study was to assess the safety and mid-term re-
sults using this novel technique to address leaflet restricted
motion or tethering of any etiology in children.MATERIALS AND METHODS
The local Ethics Committee reviewed and approved the study, and pa-
tient consent was waived.
Demographics
FromMarch 2003 through May 2009, 40 consecutive children who had
undergone mitral or tricuspid repair for regurgitation were found to have
unacceptable residual regurgitation after the use of standard repair tech-
niques such as described by Carpentier.1 These children required leaflet
suspension to the contralateral annulus (described in the present study)
as a salvage procedure to avoid potential valve replacement. A portion of
these patients had been reported previously in other studies.9-12
Of these 40 children, 36 had had this technique applied to the mitral
valve (rheumatic mitral regurgitation in 22, congenital in 11, functionalgery c November 2010
TABLE 1. Patient characteristics
Variable Total
Suspension
stitch group
Control
group
P
value
Patients (n) 80 40 40
Age (y) 11.3  3.9 11.4  3.9 11.2  4.0 .80*
Males 35 (43.8%) 15 (37.5%) 20 (50%) .27y
Previous cardiac operationz 12 (15%) 7 (17.5%) 5 (12.5%) .76y
Mitral valve repair 7 (8.8%) 3 (7.5%) 4 (10%) 1.00y
Aortic valve repair 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
AVC defect repair 2 (2.5%) 1 (2.5%) 1 (2.5%) 1.00y
Coarctation repair 2 (2.5%) 2 (5%) 0 (0%) .49y
Subaortic stenosis repair 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
Congenital coronary
anomaly repairx
2 (2.5%) 1 (2.5%) 1 (2.5%) 1.00y
Mitral valve 72 (90%) 36 (90%) 36 (90%) 1.00y
Rheumatic 44 (55%) 22 (55%) 22 (55%) 1.00y
Congenital 22 (27.5%) 11 (27.5%) 11 (27.5%) 1.00y
Functional 2 (2.5%) 1 (2.5%) 1 (2.5%) 1.00y
Degenerative 2 (2.5%) 1 (2.5%) 1 (2.5%) 1.00y
Endocarditis 2 (2.5%) 1 (2.5%) 1 (2.5%) 1.00y
Tricuspid valve 8 (10%) 4 (90%) 4 (90%) 1.00y
Dysplastic 4 (5%) 2 (5%) 2 (5%) 1.00y
Ebstein’s anomaly 4 (5%) 2 (5%) 2 (5%) 1.00y
Concomitant procedure 29 (36%) 16 (40%) 13 (32.5%) .64y
Aortic valve repair 6 (7.5%) 2 (5%) 4 (10%) .68y
Aortic valve replacement 3 (3.8%) 1 (2.5%) 2 (5%) 1.00y
Tricuspid valve repair 11 (13.8%) 6 (15%) 5 (12.5%) 1.00y
Bidirectional Glenn shunt 2 (2.5%) 2 (5%) 0 (0%) .49y
VSD repair 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
ASD repair 3 (3.8%) 2 (5%) 1 (2.5%) 1.00y
PFO repair 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
Partial AVC defect repair 1 (1.3%) 0 (0%) 1 (2.5%) 1.00y
Cox-Maze procedure 4 (5%) 1 (2.5%) 3 (7.5%) .62y
ALCAPA repair 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
Subaortic stenosis repair 1 (1.3%) 0 (0%) 1 (2.5%) 1.00y
*Independent samples Student t test between suspension stitch and control groups.
yFisher’s exact test. zPerformed at another institution. xCongenital coronary anoma-
lies included an ALCAPA repair and unroofing of congenital ostial left main coronary
artery stenosis. AVC, atrioventricular canal; VSD, ventricular septal defect; ASD,
atrial septal defect; PFO, patent foramen ovale; ALCAPA, anomalous left coronary
artery originating from the pulmonary artery.
Abbreviations and Acronyms
CI ¼ confidence interval
HR ¼ hazard ratio
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Din 1, degenerative in 1, and endocarditis in 1) and 4 to the tricuspid valve
(dysplastic tricuspid valve in 2 and Ebstein’s anomaly in 2). Their mean
age was 11.4  3.9 years. For the purpose of evaluating this novel tech-
nique, 40 additional children who had undergone similar operations and
had been matched for age, etiology, and mechanism of valve regurgitation
were used as the control group. The children in the control group had not
required techniques beyond the traditional mitral or tricuspid repair tech-
niques1 and had been identified within the same study period. All the
patients in both groups presented with type I mitral or tricuspid regurgita-
tion because of annulus dilatation, with the exception of 1 patient with
hammock mitral valve (see below), and type III regurgitation due to teth-
ering or retraction. These findings were confirmed by preoperative echocar-
diography and intraoperative valve analysis. The patient demographics of
the entire study population are summarized in Table 1.
Operative Technique
Cardiopulmonary bypass was established using ascending aortic and bi-
caval cannulation. All patients underwent surgery by the same surgeon
(A.K.) at normothermia. Myocardial protection consisted of cold antegrade
hyperkalemic crystalloid cardioplegia, repeated every 20minutes. Themitral
valve was explored through a left atriotomy performed in the interatrial
groove. Each structure of the mitral valve was analyzed systematically. In
all patients, with the exception of 2, annuloplasty was performed using a Bi-
oring Kalangos biodegradable ring (Bioring SA, Lonay, Switzerland), as de-
scribed previously.9,13 The mean annuloplasty ring size was 26.6  3.6
(range, 16-34) in the mitral position (suspension group, 26.2  3.9; control
group, 26.9  3.3; P ¼ .42), with a mean patient age of 11.3  4 years.
The mean annuloplasty ring size was 27  3.6 (range, 24-34) in the
tricuspid position (suspension group, 24.5  1.0; control group, 29.5 
3.4; P ¼ .03), with a mean patient age of 11.6  3.2 years. Two patients
did not undergo annuloplasty during the studied operation. One patient
underwent mitral valve repair in heart failure during the acute phase of
rheumatic heart disease. The repair included annuloplasty with
a biodegradable ring. Although significant posterior leaflet retraction was
noted at that time, suspension was not considered because of the extreme
fragility of the inflamed tissues. The patient developed progressively
moderate-to-severe regurgitation and underwent reoperation 3 months after
the primary operation. The suspension stitch was successfully used on the
healed, retracted posterior leaflet segments, avoiding valve replacement.
This second operation was included in the suspension stitch group. The sec-
ond patient presented with a hammock mitral valve, with significant mitral
stenosis (mean transvalvular gradient 20 mmHg). Commissurotomy, leaflet
mobilization bypapillarymuscle splitting, and suspensionofP2-P3wereper-
formed. Annuloplasty was not considered because of concerns of stenosis.
The surgical procedures included leaflet-level chordal shortening at
the free edge of the prolapsing segments, chordal transfer, secondary
or primary posterior chordal resection, commissurotomy, commissuro-
plasty, triangular resection, sliding plasty, and vegetation resection
(Table 2). Secondary chordal transfer to the primary position was mainly
used in cases of anterior leaflet prolapse due to chordal rupture or cases
of anterior leaflet pseudoprolapse due to restricted posterior leaflet
motion.
After completing these procedures, water testing revealed significant re-
sidual regurgitation owing to persistent restricted motion or tethering of
a leaflet in the 40 patients in the suspension stitch group. These patients
were considered candidates for valve replacement. Our additional tech-The Journal of Thoracic and Carnique was applied first as a salvage procedure to potentially avoid replace-
ment. A 5-0 polypropylene suture was placed on the free edge of the
retracted leaflet segment responsible for residual regurgitation and then an-
chored to the atrial side of the contralateral annulus. An autologous pericar-
dial pledget was used if the annular tissue appeared fragile (Video 1 and
Figure 1).
The length of this horizontal mattress suture was regulated while tying
its 2 strands together on the contralateral annulus. This allowed the re-
tracted or tethered leaflet to be brought up and rest closer to the natural
coaptation plane. The primary aim was to achieve coaptation, rather than
an anatomic function of the retracted or tethered leaflet. The risk of leaflet
abrasion or suture tearing over time was regarded as low, because the sus-
pended leaflet was not a part of the leaflet movement and the suture was
placed to resist the relatively low diastolic pressures. Two patients required
posterior mitral commissure suspension, and 34 required posterior mitral
leaflet suspension (Table 3). Of the 4 patients who underwent tricuspid
repair, 3 required septal leaflet suspension and 1 required posterior leaflet
suspension.diovascular Surgery c Volume 140, Number 5 1111
TABLE 2. Operative data
Variable
Entire study
population
Suspension
stitch group
Control
group
P
value
Aortic crossclamp (min) 36.0  9.3 35.4  10.3 36.6  8.3 .57*
Cardiopulmonary
bypass (min)
56.9  9.4 57.9  8.3 55.8  10.4 .31*
Valve repair technique
Ring annuloplasty 78 (97.5%) 38 (95%) 40 (100%) .49y
Leaflet-level chordal
shortening
18 (22.5%) 5 (12.5%) 13 (32.5%) .06y
Leaflet indentation
closure
46 (57.5%) 20 (43.5%) 26 (65%) .26y
Leaflet cleft closure 14 (17.5%) 7 (17.5%) 7 (17.5%) 1.00y
Commissuroplasty 22 (27.5%) 6 (15%) 16 (40%) .02y
Primary chordea
resection
11 (13.8%) 5 (12.5%) 6 (15%) 1.00y
Secondary chordae
resection
10 (12.5%) 3 (7.5%) 7 (17.5%) .31y
Chordal transfer 11 (13.8%) 5 (12.5%) 6 (15%) 1.00y
Artificial chordae 1 (1.3%) 0 (0%) 1 (2.5%) 1.00y
Triangular leaflet
resection
3 (3.8%) 3 (7.5%) 0 (0%) .24y
Sliding fundoplasty 6 (7.5%) 0 (0%) 6 (15%) .03y
Leaflet pericardial
patch augmentation
1 (1.3%) 0 (0%) 1 (2.5%) 1.00y
Papillary muscle
fenestration
11 (13.8%) 7 (17.5%) 4 (10%) .52y
Commissurotomy 8 (10%) 4 (10%) 4 (10%) 1.00y
Vegetation resection 1 (1.3%) 1 (2.5%) 0 (0%) 1.00y
Ebstein’s anomaly repair 4 (5%) 2 (5%) 2 (5%) 1.00y
*Independent sample t test between suspension stitch and control groups. yFisher’s
exact test.
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syringe to inject saline solution into the left or right ventricle. Concomitant
procedures were performed in 29 patients (Table 1). All patients underwent
intraoperative transesophageal echocardiography before skin incision and
after termination of cardiopulmonary bypass to evaluate the valvular repair.
Follow-up
Transthoracic echocardiography was performed in all patients before
surgery, before discharge from the hospital, and at 3 to 6 weeks postoper-
atively in the outpatient clinic of our institution before returning to their re-
ferring cardiologist or countries of origin. The Doppler echocardiographic
grade of mitral regurgitation was measured using color Doppler flow and
graded according to the width and length of the regurgitant jet in the left
atrium (grade I-IV). The mean gradient across the mitral valve was esti-
mated by measuring the peak diastolic velocity from the Doppler studies
in a 4-chamber view. All 80 patients (100%) were followed up in outpatient
clinics by cardiologists in their countries of origin, who periodically in-
formed us of their patient’s evolution by completing a questionnaire that
included clinical, echocardiographic, and medication information.
Follow-up for the present study was continued until December 2009. We
followed the standard published guidelines for reporting the freedom
from valve-related events.14
Statistical Analysis
Statistical analyses were performed using the Statistical Package for So-
cial Sciences software (SPSS Inc, Chicago, Ill). The data are presented as
the mean  standard deviation. Continuous variables were analyzed using1112 The Journal of Thoracic and Cardiovascular Surthe independent-samples Student t test and categorical variables using
Fisher’s exact test. Actuarial estimates were calculated using the Kaplan-
Meier method, and differences between curves were assessed using the
log-rank test. Univariate and stepwise Coxmultivariate regression analyses
were used to identify the independent predictors of the need for late reop-
eration and transvalvular gradients of 7 mm Hg or greater, as well as to as-
sess whether inclusion in the suspension stitch group was a predictor of
these 2 outcome measures. The preoperative and operative variables with
a univariate P value of< .1 and those judged to be clinically important
(age, gender, valve treated, previous cardiac surgery, concomitant cardiac
surgery, suspension stitch group vs control group) were entered into the
Cox models. Hazards ratios (HRs) for the risk factors for reoperation
were calculated using univariate andmultivariate Cox proportional hazards
estimates. All statistical tests were 2-tailed.
RESULTS
Early Outcomes
Themean aortic crossclamp and cardiopulmonary bypass
time was 36  9.3 and 56.9  9.4 minutes, respectively,
with no significant difference between the suspension stitch
and control groups (crossclamp time, 35.4  10.3 and
36.6  8.3 minutes; P ¼ .57; cardiopulmonary bypass
time, 57.9  8.3 and 55.8  10.4 minutes; P ¼ .31, respec-
tively). After applying the suspension stitch, valve replace-
ment was avoided in all 40 patients. No hospital deaths or
major postoperative morbidity occurred. No patients re-
quired reoperation within 30 days.
Late Outcomes
Follow-up was complete for all patients. The mean and
median follow-up period was 37.7  18.4 and 37 months,
respectively (range, 3 months to 7 years). The median
follow-up was 26 months for the suspension stitch group
and 41 months for the control group. This difference in me-
dian follow-up was because although both groups under-
went surgery within the studied period, we started using
the suspension technique gradually since 2003, with an ex-
ponential increase in its use with time, while the control
group underwent surgery more uniformly during the study
period. No patients died during follow-up. No thromboem-
bolic or hemorrhagic events had been observed at the latest
follow-up examinations.
A total of 5 patients (6.3%) with rheumatic mitral regur-
gitation underwent reoperation for severe mitral valve dys-
function after a mean period of 19.4  16.7 months (range,
3-43 months) from the initial mitral valve repair, 3 in the
suspension stitch group (7.5%) and 2 in the control group
(5%). The mean period to reoperation was shorter in the
suspension stitch group (mean, 8  5.6 months; median, 7
months; range, 3-14 months) than in the control group
(mean, 36.5  9.2 months; median, 36.5 months; range,
30-43 months; P ¼ .02).
The actuarial rate of freedom from reoperation for signifi-
cant valve dysfunction was 96% 2.2% at 1 year, 94.2%
2.9% at 3 years, and 91.2% 4.1% at 5 years (Figure 2). For
the suspension stitch group, the rate of freedom fromgery c November 2010
FIGURE 1. Schematic representation of suspension stitch in the mitral
position. The P2-P3 junction is suspended using polypropylene suture to
the anterior annulus over a pledget, bringing the restricted or tethered leaf-
let segment up to the coaptation plane.
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4.2% at 1 year and remained unchanged to 7 years. For the
control group, the freedom from reoperation rate was
96.6%  3.4% at 6 months and 1 and 3 years and was
91.2%  6.1% at 5 years. The difference between the 2
groups was not statistically significant (log-rank test,
P¼ .52). On Cox proportional hazardsmodeling, the suspen-
sion stitch was not a predictor of reoperation (univariate HR,
0.56; 95% confidence interval [CI], 0.09-3.38; P ¼ .53;
multivariate-adjusted HR, 1.89; 95% CI, 0.29-12.06;
P ¼ .51).
Valve Function and Transvalvular Gradients
Of the patients who required the suspension stitch, 1 pa-
tient in the mitral group had mild regurgitation at discharge
and 39 presented with trivial or no regurgitation, with
a mean transvalvular gradient of 4.4  2.4 mm Hg (range,TABLE 3. Leaflet suspension
Leaflet segment suspended n (%)
Mitral valve
P1 4 (10%)
P1-P2 3 (7.5%)
P2 3 (7.5%)
P2-P3 16 (40%)
P3 6 (15%)
P1 and P3 2 (5%)
Posterior commissure 2 (5%)
Tricuspid valve
Posterior leaflet 1 (2.5%)
Septal leaflet 3 (7.5%)
The Journal of Thoracic and Car1.3-11;>7 in 3 patients). All patients in the suspension
stitch group had no or trivial tricuspid regurgitation, with
a transvalvular gradient of 2  1.75 mm Hg. In the control
group, 2 patients in the mitral group had mild regurgitation,
with a transvalvular gradient of 3.3  2.6 (range, 2-10;>7
in 2; P¼ .09; compared with the suspension group). No pa-
tient in the control group had tricuspid regurgitation, with
a transvalvular gradient of 3.7  1.7 mm Hg (P ¼ .14).
The echocardiograms of the 75 patients who did not require
reoperation showed the repair remained stable. In the sus-
pension group, the mean transvalvular gradient slightly de-
creased to 4.2  1.6 mm Hg (range, 2-11;>7 in 1) for the
mitral valve and was unchanged at 2  1.75 mm Hg for
the tricuspid valve, with no suspension suture breakage.
In the control group, the mean transvalvular gradient de-
creased to 2.8  2.3 mm Hg (range, 1-10; >7 in 2;
P ¼ .005 compared with the suspension group) for the mi-
tral valve and 3.6  1.5 mm Hg for the tricuspid valve
(P ¼ 1.00). The left ventricular systolic dimensions (sus-
pension stitch group, 4.6  0.4 cm vs control group,
4.7  0.4 cm; P ¼ .9) and diastolic dimensions (2.8  0.5
cm vs 2.9  0.4 cm, respectively; P ¼ .74) were not signif-
icantly different between the 2 groups at the last follow-up
visit. On Cox proportional hazards modeling, the suspen-
sion stitch was not a predictor of a transvalvular gradient
of 7 mm Hg or more at latest follow-up (univariate HR,
0.98; 95% CI, 0.22-4.37; P ¼ .97; multivariate-adjusted
HR, 1.68; 95% CI, 0.3-9.3; P ¼ .56). Older age at surgery
(multivariate-adjusted HR, 0.52; 95% CI, 0.31-0.89;
P ¼ .02) and previous cardiac surgery (multivariate-
adjusted HR, 0.004; 95% CI, 0-0.71; P ¼ .04) were inde-
pendent predictors of this outcome measure.
DISCUSSION
Surgical management of mitral and tricuspid regurgita-
tion in the young is problematic because of the lack of an
ideal valve substitutewithin this age group. Prosthetic valves
have significant drawbacks, including suboptimal preserva-
tion of ventricular function, reduced survival, problems re-
lated to growth and future pregnancy, difficult lifelong
anticoagulation and panus formation for mechanical valves,
and rapid deterioration and calcification for bioprosthetic
valves.15 The long-term results of surgery for mitral regurgi-
tation have shown that repair is preferable over replacement
in terms of survival and thromboembolic and bleeding com-
plications.16 A restricted posterior leaflet is characteristic in
rheumatic mitral regurgitation.8,17 Tethering is often one of
the mechanisms responsible for regurgitation in functional
and dysplastic mitral and tricuspid regurgitation.18,19 Both
of these mechanisms of type III regurgitation are not
addressed with ring annuloplasty, although newer 3-
dimensional rigid rings have been developed for this
reason and are currently being evaluated in adults.20 One
of the tenets of Carpentier’s strategy toward valve repairdiovascular Surgery c Volume 140, Number 5 1113
FIGURE 2. Survival curves after mitral or tricuspid valve repair in 80 children. Difference between curves did not reach statistical significance (log-rank
test, P ¼ .52).
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pair.1 This often transforms the mitral valve into a function-
ally unicuspid valve with adequate leaflet coaptation from
full motion of the anterior leaflet. We postulated that by
bringing the restricted posterior leaflet up to the coaptation
plane, regurgitation could be improved sufficiently to avoid
valve replacement in patients with rheumatic mitral poste-
rior leaflet retraction. This was first done by anchoring su-
tures on the free edge of the posterior leaflet, which were
brought up to the posterior annuloplasty ring and tied
down.8 We refined this technique, postulating that by bring-
ing this suture across the valve to the opposing annulus, bet-
ter coaptation could be obtained. This technique has
subsequently been used in instances of leaflet restriction or
tethering for disorders other than rheumatic regurgitation,
as reported in the present study.
One issue during valve repair in children is the durability
of the repair, in part because of the very long life expectancy
of the patient, and in part because of the somatic growth of
the child. This issue is a particular concern because of the
possibility of iatrogenic-induced stenosis with ring annulo-
plasty and this suspension stitch. During a mean follow-up
of just longer than 3 years, no patient developed symptom-
atic mitral or tricuspid stenosis, and the transvalvular gradi-
ents decreased from amean of 4.4 2.4 mmHg to 4.2 1.6
mmHg in themitral position and remained stable at 2 1.751114 The Journal of Thoracic and Cardiovascular Surmm Hg in the tricuspid position. In the control group, the
mean gradients decreased from 3.3  2.6 to 2.8  2.3 mm
Hg in the mitral position and 3.7  1.7 to 3.6  1.5 mm
Hg in the tricuspid position. Although the relative change
in the gradient was not significant within each group and po-
sition, the gradients were significantly lower statistically in
the control group than in the suspension stitch group in the
mitral position at the latest follow-up. This stability in the
transvalvular gradients in both groups was consistent with
our experience using the Bioring Kalangos biodegradable
annuloplasty ring in children in the mitral position.9 It is im-
portant to note that all the patients in the present study, with
the exception of 1, underwent annuloplasty with a Bioring
Kalangos biodegradable ring. This could explain this de-
crease in gradients during follow-up.We previously showed
that of 220 children with rheumatic mitral regurgitation,
those who underwent annuloplasty with a Carpentier-
Edwards ring had a mean increase of 1.8 mm Hg during
the first year compared with 0.5 mm Hg in children who re-
ceived a biodegradable annuloplasty ring.9 In an experimen-
tal juvenile pig model, in which the pigs’ mean weight
increased by 500% during the year of follow-up after Bior-
ing implantation, transvalvular gradients remained stable
and the measured valve area showed regular somatic
growth.13 Mrowczynski and colleagues showed that the tri-
cuspid annulus continues to grow after Bioring implantationgery c November 2010
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in children with congenital tricuspid regurgitation (unpub-
lished data, presented at the Society of Thoracic Surgeons
2010 Annual Meeting, Poster P48). It is thus possible that
the relatively low rates of reoperation and elevated trans-
valvular gradients were favorably biased by the use of this
biodegradable ring. Thus, caution is advised if applying
the results of the present study to other annuloplasty devices
or techniques.
The present studywas limited by the relatively small sam-
ple size, retrospective, nonrandomized design, and midterm
follow-up. Both groups were matched for the presence of
leaflet restricted motion or tethering, age, valve treated,
and etiology of valve disease and no significant differences
in the preoperative patient characteristics were found. How-
ever, the control group was not exactly similar because the
standard repair techniques were sufficient to relieve leaflet
restriction or tethering without resorting to our additional
suspension stitch in the control group. Furthermore, the sam-
ple size did not allow for propensity score analysis. The use
of the suspension stitch was determined by subjective crite-
ria at water testing of the mitral or tricuspid valve when the
standard techniques were not sufficient to decrease the de-
gree of residual insufficiency. Thus, a selection bias could
not be ruled out. The multivariate models used for Cox pro-
portional hazards modeling were limited by the number of
events. Only 5 events occurred for 8 degrees of freedom in
the models using reoperation as an outcome and 7 events
in the models using a high transvalvular gradient as an out-
come. However, 5 to 10 times more events than degrees of
freedom are usually recommended. Finally, follow-up echo-
cardiographic data were mostly interpreted and analyzed by
the referring cardiologist in the patients’ country of origin.
This introduced the risk of estimator bias, because the echo-
cardiographic images could not be interpreted by an inde-
pendent echocardiography laboratory unaware of the
surgery and clinical outcome. Furthermore, more detailed
data, such as the right ventricular dimensions, or quantitative
methods of grading regurgitation, such as the actual width of
the vena contracta or proximal isovelocity surface area,
could not be obtained in a large proportion of patients.
CONCLUSIONS
The suspension technique described is simple and safe. It
moves the retracted or tethered leaflet up to the coaptation
plane, thus creating a larger coaptation area that can elimi-
nate regurgitation. In our experience of 40 children, ade-
quate leaflet coaptation was achieved and allowed the
avoidance of valve replacement. This result was maintained
in all but 3 children during a median follow-up of 37 months
and extending up to 7 years. No technical failures of the
stitch and no leaflet abrasion occurred during follow-up.
Also, stenosis did not develop. These results were compara-
ble to the results in the control group.The Journal of Thoracic and CarReferences
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Dr Luca Vricella (Baltimore, Md). I would like to thank the or-
ganizing committee for the privilege of starting the discussion on
this very interesting series of patients with mitral valve regurgita-
tion and Dr Myers for kindly providing me in advance with thediovascular Surgery c Volume 140, Number 5 1115
Congenital Heart Disease Myers et al
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Dmanuscript and video for this presentation. Let me congratulate the
group in Geneva and Dr Kalangos, in particular, on their outstand-
ing results with mitral valve repair in children. I have a few com-
ments and 3 questions.
This particular technique is really a modified Alfieri suture. The
difference is that the posterior leaflet is displaced superiorly and
anteriorly rather than creating a double orifice valve. I can see
how in patients with isolated posterior leaflet restriction, which
was the case, this would have minimal impact on creating stenosis
and also only create diastolic stress on the suture. I assume that the
suspension is performed in all cases after placement of an annulo-
plasty ring and immediately after saline testing rather than after
a first attempt at weaning from cardiopulmonary bypass. So you
are actually testing the valve with a subjective test, and then you
come off bypass after putting the stitch, thereby acting on objective
data that documents regurgitation. So it might be the annuloplasty
band that corrects the regurgitation, rather than your suture, you
just do not know.
So, my first question is, in these cases, you used a particular re-
absorbable or partial ring with an average size of 26 mm in a group
of patients with a mean age of 11 years. Do you think that a similar
result could have been achieved by slightly undersizing the annu-
loplasty? In other words, how significant was the contribution of
type I regurgitation, because you brought the diameters down to
26 mm, which is a size very close to an adult-size mitral valve?
Also, in the manuscript, as you said, these patients all had type I
and type III abnormalities.
Dr Cikirikcioglu. Thank you very much for your comments.
The mean size of the biodegradable ring in this series was 26.
However, when we looked at all the patients, there are some
smaller sizes, used in younger children, which are not available
in traditional rings. However, the use of the appropriate biodegrad-
able ring size allows us to keep the transmitral gradient stable dur-
ing the follow-up period. In our opinion, it is not really the best
option to ensure a better coaptation surface only by using under-
sized valvuloplasty in these patients in whom the posterior leaflet
is severely retracted and tethered.
Dr Vricella. But you actually did do that in 40 patients in this
series, right, you just did an annuloplasty ring?
Dr Cikirikcioglu. Yes, with associated repair techniques.
Dr Vricella. The second question is: At the time of the oper-
ation in the suspension stitch group, you performed secondary
and primary chordal shortening and triangular leaflet, resection
in a substantial number of patients. These techniques are also of-
ten used in patients who have type II motion abnormality. So the
question here is you also performed leaflet indentation closure
and commissuroplasty in 43% and 15% of patients in this group.
So, these can actually pull tissue away from the anterior leaflet.
Is it possible that in a fair amount of patients in this group,
restriction was actually worsened by aggressive use of these
techniques?
Dr Cikirikcioglu. Secondary and primary chordal transfer was
used to correct the pseudoprolapse of the anterior leaflet secondary
to the posterior leaflet retraction.1116 The Journal of Thoracic and Cardiovascular SurDr Vricella. I can just see how if you actually start plicating or
doing triangular resections, you can actually pull the 2 leaflets
away from their coaptation area, so it was a concern of mine.
The last question I had was: What were the findings at the time
of the reoperation in the 3 patients with late failure in suspension
group? The time to reintervention in this particular group was sig-
nificantly shorter, it was 8 versus 36 months.
Dr Cikirikcioglu. It was our will to push the limits too much to
repair these more severely affected rheumatic mitral valves in the
suspension stitch group compared with the control group. I think
the reoperations were not related to the techniques but to the sever-
ity of the rheumatic disorder.
Dr Vricella.Well, congratulations on your presentation. I think
your excellent results underscore the importance of trying at all
costs to repair valves in children rather than to replace them.
Dr Marshall Jacobs (Cleveland, Ohio). It is a very, very nice
presentation of your technique and a nice analysis.
Echoing something that was in the primary discussant’s com-
ments, it appeared from your data that the aortic crossclamp
time was virtually the same for the suspension stitch group and
the other group, which means it did not take you long to do it.
Also, I assume, based on your enthusiasm for the procedure, that
your threshold for doing it is probably lowish, because you see
very little downside.
On the other hand, like the previous discussant, I find it very sur-
prising that you reported no cases in which you did a repair, came
off cardiopulmonary bypass, found residual regurgitation that you
thought might be attributed to immobility or tethering, and went
back and solved that problem by placement of a tethering stitch.
Have you had that experience? Were there any such cases that per-
haps were not in this series?
Dr Cikirikcioglu. Based on our repair strategy, in occasional
cases, we went back to solve the residual regurgitation. Also, as
you noticed in the video, if you have residual regurgitation after
repair, it is not logical to leave this residual regurgitation.
Our strategy is, first to obtain the best coaptation surface with-
out any residual leak and then to see the dynamic final result on the
transesophageal echocardiogram.
DrKhanh Nguyen (New York, NY). I really enjoyed the presen-
tation. I noticed that you only spend 1% of the time trying to do
artificial chord placement. I am wondering whether you can re-
lease the tethered leaflet, lift it by just transecting the chord that
is holding it down, and use Gore-Tex chords. Also, I would think
that that would release the restriction significantly. Have you tried
that technique?
Dr Cikirikcioglu. It is another option you can use. I mean, this
technique can be useful also, I agree. But, in my opinion, our sus-
pension technique is fast and reproducible and safe, and our mid-
term results are good. Usually these cases are coming to surgery at
late stage with bad ventricular function. Thanks to the suspension
technique, we are able to decrease the crossclamping time. For this
reason, I agree with you, resection of retracted primary chordae
and their replacement with an artificial chordae can also be used
as an alternative technique, but we did not do that.gery c November 2010
